A UK study has found that obesity jabs could reduce health risks.
Researchers looked at semaglutide, otherwise known as Wegovy and Ozempic, and found that the weekly shots could reduce the risk of heart attacks and strokes.
It was found to benefit cardiovascular health even if the user didn’t lose much weight.
UK Correspondent Gavin Grey told Roman Travers that it’s too early to say that it’s definitely working and definitely a side effect, but the potential is fascinating.
LISTEN ABOVE

Kevin Putt: Former Springbok previews the final Greatest Rivalry test between the All Blacks and Springboks
02:18

Leon Panetta: Former Defence Secretary and CIA Director on the US-Iran war
08:17

Graeme Edgeler: Constitutional law expert on an MSD review which found more than 30-thousand cases, where benefits and payments were wrongly suspended
04:04